@stockrock
Very interested in your views, you strike me as a more objective holder of this stock than some.
I have been puzzled by the whole financing equity business, the announcement back in June did talk about a "placement" which certainly implied a private group of investors (to me at least).
That said, I believe the possibility of these shares being sold on the open market at a price that meets Mesoblast "minimum price" will be the realistic option. In the end, if Kentgrove can dribble them out to the market place at a price that meets Mesoblast's stated minimum price, that is what they will do.
Regarding "If he specifically said that capital raised from the Kentgrove facility would be non-dilutive," it is worth listening to what the ceo said from about 22:35 on the link below, particular what they "would not be doing to shareholders".
https://boardroom.media/broadcast/?refid=&eid=57589faf4c64e59e61dc747e
Morningstar $2.10 valuation, page-34
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
-0.050(4.39%) |
Mkt cap ! $1.244B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.17 | $1.07 | $8.385M | 7.489M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8500 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 26954 | 3 |
View Market Depth
| Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |